Effect of SBG in Patients With Breast Cancer

• Status: Completed
• Trial end date: 2010-01-01

Summary

This study is set up to determine whether soluble beta-glucan (SBG) has

• unfavourable side effects

• beneficial treatment effects when given in combination with standard antibody and chemotherapy to patients with breast cancer.

• Phase: Phase 1/Phase 2

Details

• Lead Sponsor: Biotec Pharmacon ASA